Atlas Trials

Adelbelimab Combination Chemotherapy in Neoadjuvant Therapy for Squamous Cell Carcinoma of the Head and Neck

Clinical trial NCT06016413 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06016413
Sponsor
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Status
NOT_YET_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Head and Neck Squamous Cell Carcinoma
Start date
2023-09-01
Primary completion
2024-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.